Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.

被引：0
|
作者：
Kumar, S [1 ]
Lacy, M [1 ]
Inwards, D [1 ]
Litzow, M [1 ]
Tefferi, A [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
804
引用
收藏
页码：192A / 192A
页数：1
相关论文
共 50 条
  • [41] DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE
    Antmen, B.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    HAEMATOLOGICA, 2016, 101 : 628 - 628
  • [42] Hepatic veno-occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation
    Mori, Takehiko
    Aisa, Yoshinobu
    Shimizu, Takayuki
    Yamazaki, Rie
    Mihara, Ai
    Yajima, Tomoharu
    Hib, Toshifumi
    Ikeda, Yasuo
    Okamoto, Shinichiro
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (09) : 838 - 839
  • [43] Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies
    Ho, V. T.
    Revta, C.
    Richardson, P. G.
    BONE MARROW TRANSPLANTATION, 2008, 41 (03) : 229 - 237
  • [44] Low incidence of hepatic veno-occlusive disease after fractionated doses of Mylotarg and autologous or allogeneic stem cell transplantation.
    Farhat, H
    Raffoux, E
    Isnard, F
    Contentin, N
    Taksin, AL
    Dombret, H
    Castaigne, S
    Rousselot, P
    BLOOD, 2005, 106 (11) : 409B - 410B
  • [45] DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE
    Antmen, B.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    HAEMATOLOGICA, 2017, 102 : 623 - 623
  • [46] Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience
    Antmen, B. A.
    Sasmaz, I.
    Karagun, B.
    Serbest, M.
    Ucar, G.
    Baysal, T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5580 - 5580
  • [47] Prophylactic defibrotide for the prevention of hepatic veno-occlusive disease (VOD) in hematopoietic stem cell transplantation (HSCT).
    Joshi, R
    Kerridge, I
    Grace, S
    Ethell, M
    Potter, M
    Prentice, HG
    BLOOD, 2002, 100 (11) : 413A - 414A
  • [48] High dose corticosteroids for treatment of hepatic veno-occlusive disease (VOD) complicating stem cell transplantation.
    Khoury, H
    Adkins, D
    Brown, R
    Goodnough, T
    DiPersio, J
    BLOOD, 1996, 88 (10) : 1646 - 1646
  • [49] Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
    Veronika Schneider
    Karin M. Cabanillas Stanchi
    Karina Althaus
    Sarah Schober
    Sebastian Michaelis
    Christian Seitz
    Peter Lang
    Rupert Handgretinger
    Tamam Bakchoul
    Stefanie Hammer
    Michaela Döring
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 8443 - 8453
  • [50] Low Incidence of hepatic veno-occlusive disease in adults undergoing allogeneic hematopoietic stem cell transplantation
    Stutz, L.
    Halter, J.
    Heim, D.
    Passweg, J.
    Medinger, M.
    SWISS MEDICAL WEEKLY, 2021, 151 : 29 - 29
12345